Reduced CXCR4 receptor was detected in MM patients undergoing bortezomib treatment, which can be an indication of impaired adhesion and increased expression of macrophage migration inhibitory factor (MIF) [54,55]. Here, MIF is linked to Miyoshi myopathy.